Eric Venker, MD, PharmD

• Chief Executive Officer of Immunovant and member of the Board of Directors since 2020

• President of Roivant Sciences; previously served as Roivant’s Chief Operating Officer, Chief Medical Officer, and Chief of Staff to the CEO

• More than two decades of clinical practice and operating experience across biotechnology, pharmaceuticals, and healthcare systems

• Former physician at NewYork-Presbyterian Hospital / Columbia University Medical Center, where he led operational initiatives across a large hospital system

• M.D. from Yale School of Medicine; Pharm.D. from St. Louis College of Pharmacy